This Article Full Text Full Text (PDF) All Versions of this Article: 110/7/826    most recent 01.CIR.0000138741.72946.84v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Muthurangu, V. Articles by Razavi, R. S. Search for Related Content PubMed PubMed Citation Articles by Muthurangu, V. Articles by Razavi, R. S. Pubmed/NCBI databases Medline Plus Health Information MRI Scans Pulmonary Hypertension Related Collections Pulmonary circulation and disease CT and MRI Endothelium/vascular type/nitric oxide

(Circulation. 2004;110:826-834.)
© 2004 American Heart Association, Inc.

Original Articles

Novel Method of Quantifying Pulmonary Vascular Resistance by Use of Simultaneous Invasive Pressure Monitoring and Phase-Contrast Magnetic Resonance Flow

Vivek Muthurangu, BSc, MBChB, MRCPCH; Andrew Taylor, MD, MRCP, FRCR; Rado Andriantsimiavona, MSc; Sanjeet Hegde, MBBS, MRCPCH; Marc E. Miquel, PhD; Robert Tulloh, DM, MA, MRCP, FRCPCH; Edward Baker, MD, FRCP; Derek L.G. Hill, PhD; Reza S. Razavi, MBBS, MRCP, MRCPCH

From the Cardiac MR Research Group, Division of Imaging Sciences, King’s College (V.M., A.T., R.A., S.H., M.E.M., D.L.G.H., R.S.R.); the Department of Congenital Heart Disease, Guy’s Hospital (R.T., E.B., R.S.R.); and the Cardiothoracic Unit, Institute of Child Health and Great Ormond Street Hospital (A.T.), London, United Kingdom.

Correspondence to Dr R. Razavi, 5th Floor, Guy’s Hospital, London SE1 9RT, UK. E-mail reza.razavi{at}kcl.ac.uk

Received October 2, 2003; de novo received December 12, 2003; revision received March 30, 2004; accepted April 2, 2004.

Background— Pulmonary vascular resistance (PVR) quantification is important in the treatment of children with pulmonary hypertension. The Fick principle, used to quantify pulmonary artery flow, may be a flawed technique. We describe a novel method of PVR quantification by the use of magnetic resonance (MR) flow data and invasive pressure measurements.

Methods and Results— In 24 patients with either suspected pulmonary hypertension or congenital heart disease requiring preoperative assessment, PVR was calculated by the use of simultaneously acquired MR flow and invasive pressure measurements (condition 1). In 19 of the 24 patients, PVR was also calculated at 20 ppm nitric oxide +30% (condition 2) and at 20 ppm nitric oxide +100% oxygen (condition 3), with the use of the MR method. This method proved safe and feasible in all patients. In 15 of 19 patients, PVR calculated by Fick flow was compared with the MR method. At condition 1, Bland-Altman analysis revealed a bias of 2.3% (MR > Fick) and limits of agreement of 50.2% to –45.5%. At condition 2, there was poorer agreement (bias was 28%, and the limits of agreement were 151.3% to 95.2%). At condition 3, there was very poor agreement (bias was 54.2%, and the limits of agreement were 174.4% to –66.0%).

Conclusions— We have demonstrated the feasibility of using simultaneous invasive pressure measurements and MR flow data to measure PVR in humans.

Key Words: vasculature • magnetic resonance imaging • catheterization

This article has been cited by other articles:

				H. M. Müller, P. H. Rehak, M. Puchinger, D. Wagner, W. Marte, and K.-H. Tscheliessnigg Measurement of cardiac output and pulmonary transit time for assessment of pulmonary vascular resistance in domestic piglets Exp Physiol, June 1, 2009; 94(6): 659 - 664. [Abstract] [Full Text] [PDF]

				A. Crean Cardiovascular MR and CT in congenital heart disease Heart, December 1, 2007; 93(12): 1637 - 1647. [Full Text] [PDF]

				A. Vonk-Noordegraaf, J.-W. Lankhaar, M. J.W. Gotte, J. T. Marcus, P. E. Postmus, and N. Westerhof Magnetic resonance and nuclear imaging of the right ventricle in pulmonary arterial hypertension Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H29 - H34. [Abstract] [Full Text] [PDF]

				V. Muthurangu, A. M. Taylor, S. R. Hegde, R. Johnson, R. Tulloh, J. M. Simpson, S. Qureshi, E. Rosenthal, E. Baker, D. Anderson, et al. Cardiac Magnetic Resonance Imaging After Stage I Norwood Operation for Hypoplastic Left Heart Syndrome Circulation, November 22, 2005; 112(21): 3256 - 3263. [Abstract] [Full Text] [PDF]

				N. Alphonso, M. Baghai, P. Sundar, R. Tulloh, C. Austin, and D. Anderson Intermediate-term outcome following the fontan operation: a survival, functional and risk-factor analysis Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 529 - 535. [Abstract] [Full Text] [PDF]

				V. Muthurangu, D. Atkinson, M. Sermesant, M. E. Miquel, S. Hegde, R. Johnson, R. Andriantsimiavona, A. M. Taylor, E. Baker, R. Tulloh, et al. Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1301 - H1306. [Abstract] [Full Text] [PDF]

				V Muthurangu and R S Razavi The value of magnetic resonance guided cardiac catheterisation Heart, August 1, 2005; 91(8): 995 - 996. [Full Text] [PDF]

				T Kuehne, S Yilmaz, I Schulze-Neick, E Wellnhofer, P Ewert, E Nagel, and P Lange Magnetic resonance imaging guided catheterisation for assessment of pulmonary vascular resistance: in vivo validation and clinical application in patients with pulmonary hypertension Heart, August 1, 2005; 91(8): 1064 - 1069. [Abstract] [Full Text] [PDF]